NCT07487649 Treatment Response in Patients With Medication-Overuse Headache
| NCT ID | NCT07487649 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sultan 1. Murat State Hospital |
| Condition | Medication-overuse Headache |
| Study Type | OBSERVATIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-03-17 |
| Primary Completion | 2026-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 70 participants in total. It began in 2026-03-17 with a primary completion date of 2026-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study to evaluate pre-injection patient-related factors that may influence treatment response in patients with medication-overuse headache who underwent ultrasound-guided greater occipital nerve block.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 65 years * Diagnosis of medication-overuse headache according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) * Diagnosis of medication-overuse headache associated with the use of triptans or nonsteroidal anti-inflammatory drugs * Previous diagnosis of chronic migraine or chronic tension-type headache according to the ICHD-3 criteria Exclusion Criteria: * History of severe head or neck trauma or previous neurosurgical intervention * Presence of a severe psychiatric disorder (e.g., severe depression, schizophrenia) * History of infectious disease, chronic inflammatory disease, or malignancy * Previous diagnosis of secondary headache * History of substance abuse * Pregnancy or breastfeeding * History of an additional neurological disorder (e.g., cerebrovascular disease, multiple sclerosis) * Difficulty with cooperation * Presence of a concomitant systemic disease that may affect quality of life (e.g., congestive heart failure, chronic kidney disease, chronic liver disease, pulmonary disease, uncontrolled diabetes, or peripheral vascular disease)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07487649 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Medication-overuse Headache. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07487649 currently recruiting?
Yes, NCT07487649 is actively recruiting participants. Contact the research team at dralpmengi@gmail.com for enrollment information.
Where is the NCT07487649 trial being conducted?
This trial is being conducted at Edirne, Turkey (Türkiye).
Who is sponsoring the NCT07487649 clinical trial?
NCT07487649 is sponsored by Sultan 1. Murat State Hospital. The trial plans to enroll 70 participants.